Skip to main content
Premium Trial:

Request an Annual Quote

Richard Popp, Paul Markham, Bill Brundage, Ernie Fletcher, Gianfranco de Feo, Emily Winn-Deen, Joseph Smith, Margaret Tempero, Greg Lucier, Peter Wilver, Theo Melas-Kyriazi

Richard Popp joins Advanced Technology Ventures of Palo Alto, Calif., in the position of technology partner. Popp will retain his appointment as a professor of medicine in the division of cardiovascular disease at the Stanford University School of Medicine as well as the position of director of ethics and policy for the Stanford Program in Biodesign. He is also principal medical consultant for both Agilent Labs and HP Labs.

Paul Markham, a 10-year veteran in senior sales and marketing positions at GE Healthcare Information Technologies, joins TeraMedica of Milwaukee, Wisc., as vice president of marketing. Markham will manage sales and marketing, and will oversee the brand development of the TeraMedica Information Solution, an enterprise archive solution that manages and converts medical records into digital images. TeraMedica was incorporated in 2001 and is a subsidiary of the radiology informatics laboratory of the Mayo Clinic.

Bill Brundage, Kentucky’s first commissioner of the new economy, has accepted a $50,000 contract to run through June 30, 2005, to facilitate technology transfer form the University of Louisville’s research efforts, according to a report in the Louisville Business First publication. His previous duties ended in July when Kentucky Gov. Ernie Fletcher restructured the organization, renaming it the Economic Development Cabinet’s Department of Innovation and Commercialization for the Knowledge-Based Economy. In his previous duties, Brundage’s office supported the university’s development of a proteomics program; expansion of the James Graham Brown Cancer Center; and development of the Cardiovascular Innovation Institute.

Gianfranco de Feo, former associate director for genomics collaborations at Affymetrix, joined Guava Technologies of Hayward, Calif., as director of customer support and service, the company said this week. Previously, he was a field application specialist at PerkinElmer/Applied Biosystems.

Emily Winn-Deen joins Cepheid of Sunnyvale, Calif., in the new position of vice president of strategic planning and business development, reporting to Joseph Smith, senior vice president for legal and business development, the company said. Winn-Deen joined Cepheid from her post as head of the genomics business group at Roche Molecular Systems in Pleasanton, Calif. Previously, she worked at Applied Biosystems and Celera Genomics, where she established Celera’s high-throughput genotyping laboratory, and the genotyping services business.

Margaret Tempero and Greg Lucier have been named keynote speakers at the BIO Emerging Company Investor Forum Oct. 13-15 in San Francisco. Tempero is director of clinical services and deputy director of the Comprehensive Cancer Center of the University of California at San Francisco and a professor and chief of the division of medical oncology. Lucier is the chairman and chief executive officer of Invitrogen.

Peter Wilver has replaced Theo Melas-Kyriazi as chief financial officer of Thermo Electron, the company said in an SEC filing this week. Melas-Kyriazi had announced his resignation in June, effective Oct. 1. Wilver takes the CFO post after serving as Thermo’s vice president of financial operations since October 2000, Previously, he was vice president and chief financial officer of Honeywell International’s electronic materials division and served as finance director of its aerospace aftermarket services business.

The Scan

Support for Moderna Booster

An FDA advisory committee supports authorizing a booster for Moderna's SARS-CoV-2 vaccine, CNN reports.

Testing at UK Lab Suspended

SARS-CoV-2 testing at a UK lab has been suspended following a number of false negative results.

J&J CSO to Step Down

The Wall Street Journal reports that Paul Stoffels will be stepping down as chief scientific officer at Johnson & Johnson by the end of the year.

Science Papers Present Proteo-Genomic Map of Human Health, Brain Tumor Target, Tool to Infer CNVs

In Science this week: gene-protein-disease map, epigenomic and transcriptomic approach highlights potential therapeutic target for gliomas, and more